chrisvoncsefalvay/vaers-outcomes huggingface dataset:
c/o pain 4-6wk p/2nd dose vax;pain never ceased but became more intense p/2nd dose;c/o wrist pain bilat & rt shoulder pain for past 4wk;pt saw chiropractor x 3-no relief;
Arm was not that sore, a little bit/Arm was not that sore, a little bit; This is a spontaneous report from a contactable consumer(patient). A female patient of unspecified age started to receive second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL9261), via an unspecified route of administration at arm in Jan2021 at single dose for covid-19 immunisation. Medical history and concomitant medication were not reported. Patient previously took the first dose of bnt162b2 at single dose for covid-19 immunisation (The 1st dose was Pfizer EL, then it has a 0 with a line through it. And then 14 and then another 0 with a line through it). Reporter asked if the vaccine make antibodies. if she needed an antibody test since she has only had mild soreness as a side effect. Her companion had the vaccine with another person and had no side effects either. they had it at a medical school so hopefully they had people who knew what they were doing. She was hoping the doses were good. she got the second dose of the Covid 19 vaccine last week on Wednesday. She has had no side effects other than a little bit of a sore arm (Jan2021). She has heard the second dose of the vaccine causes more side effects than the first and that was supposed to show that the vaccine is taking effect. She asked if it was correct. She is not questioning if the vaccine was given correctly or not.  She asked if there was anything that states how many people had no side effects. She had the second vaccine Pfizer, last Wednesday. And she had heard that it gives one some fever and may be chills or small things that shows that one are taken it and what worries them was they had no symptoms at all. Even her arm was not that sore, a little bit. But she just wondered if there had people that had no symptoms does that mean it did not take. she was worried because they do not have any symptoms. Outcome of the event was unknown.
Pt was given the H1N1 FluMist and should have gotten the shot. No adverse reactions reported.
Developed right lower extremity DVT and pulmonary emboli after travel out of state where vaccine was administered. Presented to ED and diagnosed with VTE, placed on rivaroxaban and referred to hematologist.
As reported on an incident report on 1/27 @17:21: "After receiving vaccination, patient became hypotensive and diaphoretic. Was reported to me that after visitor received vaccination injection she became diaphoretic, BP low, and FSBS. Visitor was observed and refused ED treatment. Left [building] ambulatory in no obvious distress"
Pt experienced severe swelling on the underside of the arm (same are as the injection but several inches away from the injection site). We contacted Merck and were advised that the reaction should diminish within 48 hours. Pt was consulted regarding any other symptoms (none were present) and informed to monitor the situation and contact MD if other symptoms arose. Reaction did go away within the 48 hour time frame.
Pt developed  throat tightness, shortness of breath. WAs given benadryl and famotidine and recovered  after  45 minutes  of observation
I had a fever for 5 days, and return of joint pain in the Left elbow that had finally resolved after Covid (that started w my Covid infection in August 2020).  I have also developed, since the vaccine, and temperature change between my R and L hands, as well as some persistent sensory change in my R hand
**Patient has fully transitioned to male has had everything removed** Woke up around 3AM fever, chills, blisters going back and lower arm. I have one on my hand and I have line going up to my elbow then on  blisters on my back as well. It looks like chicken pox.  They are itching and hurt.   Has called his doctor, sent over photos of the "blisters" still waiting for a call back
I also got the flu; Initial information was received on 30-Nov-2022 regarding an unsolicited valid Social Media non-serious case received from a consumer/non-health-care professional.  This case involves Adult and unknown gender patient who reported i also got the flu after receiving influenza vaccine.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  On an unknown date, the patient received an unknown dose of suspect influenza vaccine produced by unknown manufacturer (unknown formulation) (lot number, expiry date, strength, frequency was unknown) via unknown route in unknown administration site for Influenza immunization.  On an unknown date the patient had a non-serious event i also got the flu (influenza) (unknown latency) following the administration of influenza vaccine.  Action taken: not applicable.  It was not reported if the patient received a corrective treatment for the event.  At time of reporting, the outcome was Unknown for the event.
Fever, chills, joint ache, sore throat, weakness, and dizziness.
This spontaneous report as received from a physician refers to a patient of unknown age who in about July 2011, was vaccinated with the first dose of GARDASIL intramuscularly (dose and lot number not provided). Other co-suspects were not reported. Concomitant medications were not reported. It was reported that the patient on 26-JUL-2012, was vaccinated with the second dose of GARDASIL intramuscularly (dose and lot number not provided). At the time of the report, no known adverse effects. Additional information has been requested.
round pinkish, tender swelling on the injection site; she noted a round pinkish; itchiness on the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (itchiness on the injection site), VACCINATION SITE SWELLING (round pinkish, tender swelling on the injection site) and VACCINATION SITE ERYTHEMA (she noted a round pinkish) in a 37-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 11-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Jan-2021, the patient experienced VACCINATION SITE PRURITUS (itchiness on the injection site). On 20-Jan-2021, the patient experienced VACCINATION SITE SWELLING (round pinkish, tender swelling on the injection site) and VACCINATION SITE ERYTHEMA (she noted a round pinkish). At the time of the report, VACCINATION SITE PRURITUS (itchiness on the injection site), VACCINATION SITE SWELLING (round pinkish, tender swelling on the injection site) and VACCINATION SITE ERYTHEMA (she noted a round pinkish) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication were not reported by the reporter. Treatment details were not reported by the reporter.
Breast cancer; This is a spontaneous report from a non-contactable consumer (patient's husband).  A female patient of an unspecified age received bnt162b2 (BNT162B2), via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as DOSE NUMBER UNKNOWN, SINGLE for covid-19 immunisation  .  The patient medical history was not reported. Concomitant medication(s) included ivermectin (IVERMECTIN) taken for an unspecified indication, start and stop date were not reported.  The  reporter stated his wife took vaccine, and she got breast cancer on an unspecified date with outcome of unknown.    No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
This spontaneous report was received from a physician via a company representative, referring to a patient of unknown age and gender. No information regarding the patient's medical history, concurrent conditions or concomitant therapies was provided. On 06-MAR-2015, the patient was vaccinated with the improperly stored dose of PNEUMOVAX 23 "10 PK 0.5 ml SD-PFS LLok w Tip" lot number K009106 with expiration date of 25-FEB-2016 (dose number, route of administration and anatomical location were not provided), which was stored at -2.77 Celsius Degrees for 384 hours. The type of excursion was refrigerator. No adverse effects were reported. No product quality complaint was involved. This is one of several cases from the same reporter. Additional information has been requested.
same day of injection - large area of swelling 6 cm, vomiting, high fever, chills,  hallucinations, severe joint pain , fatigue, discoloration and pain in hands.
This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. A 41-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), as dose 3 (booster), single (Batch/Lot number: unknown), in left arm for covid-19 immunization; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown) and as dose 2, single (Batch/Lot number: unknown) for covid-19 immunization. The patient had no relevant medical history. There were no concomitant medications. The following information was reported: DRUG INEFFECTIVE (medically significant), SUSPECTED COVID-19 (medically significant), outcome "unknown" and all described as "COVID 19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Unknown results, notes: Treatment of COVID-19. Therapeutic measures were taken as a result of drug ineffective, suspected covid-19. No other medication in 2weeks. COVID 19 Treatment, Paxlovid, from 30May2022 to 03Jun2022.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Screamed w/piercing cry for most of 11hrs; Given Tylenol q 3 hrs; Slept most of 29MAR then on 30MAR screamed & was fussy for 11 hrs; Today 2APR91 has rash-little red dots on ears chest/ 3APR91 recovered;
Pt developed malaise, loss of appetite, body aches, nausea and weight loss. Recovery is ongoing. Mild effects on the same day, but continued to get worse after 2 days. Pt is going to travel to Africa and other places. She was given mefloquine prescription.
pink spot below the injection site after second dose; This spontaneous case was reported by a patient and describes the occurrence of VACCINATION SITE DISCOLOURATION (pink spot below the injection site after second dose) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 051C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 19-Jun-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Jun-2021, the patient experienced VACCINATION SITE DISCOLOURATION (pink spot below the injection site after second dose). At the time of the report, VACCINATION SITE DISCOLOURATION (pink spot below the injection site after second dose) outcome was unknown. Not Provided          No concomitant medications were reported. No treatment information was provided by the reporter.    This case was linked to MOD-2021-230043 (Patient Link).
This patient an 82-year-old female comes to the emergency department mainly complaining of right arm pain. She had her pneumococcal vaccine shot today around 12 o'clock and then several hours later started to develop right arm pain particularly in the shoulder where she got her shot, that was followed with episode of nauseousness and dizziness which she said she felt a little lightheaded. She denied any chest pain, palpitation, shortness of breath with it. Positive nausea with no vomiting. She denied any other symptoms with the exception of that. Her shoulder pain is worse with movement and she has trouble lifting her arm because of that discomfort. She only weighs 100 pounds, does not have a lot of subcutaneous tissue and/or muscle of that shoulder. She denies any redness, fevers, paraesthesias or weakness. No focal complains. Heart: No chest pain or tachycardia. Lungs: No wheezing or shortness of breath. Abdomen: Positive nausea, no vomiting. No diarrhea or constipation or abdominal pain. GU: No hematuria or dysuria. Remainder of systems reviewed are negative except as above. Nursing notes noted. Vital signs: Blood pressure 162/68, heart rate of 91, respiratory of 18, temperature 35.9. She is 96: on room air. Constitutional: She is alert, oriented x3, nontoxic, afebrile. Answering questions appropriately, acting appropriate for age, in no acute distress. HEENT: Pupils are equal, round, react to light. Extraocular muscles are intact. Mucous membranes are moist. Neck is supple without lymphadenopathy. There is no meningismus. Chest: Regular rate, no S3, S4 or murmurs. Lungs are clear to auscultation bilaterally. No wheeze, rhonchi or rales, no tachypnea, no retractions, no stridor. Abdomen is soft, nontender, nondistended with positive bowel sounds in all 4 quadrants. Extremities: No clubbing, cyanosis or edema. Right upper extremity there is marked tenderness to palpation over the lateral aspect of the right shoulder, there is sign of where her injection was but there is no erythema, no ecchymosis, no swelling, just significant tenderness to palpation there. Grip strength is +5/5 bilaterally. Neurologic: She is moving all 4 extremities. There are no gross focal neurologic deficits. Decreased range of motion secondary to pain in the right upper extremity but no focal weakness. Skin warm and dry. She was given a small dose of MORPHINE, as well as ZOFRAN and she was reevaluated. She was markedly improved. She denied any nauseousness. She was still complaining of pain in her right arm and understands that that is going to be probably like that for the next 2 to 3 days. Return if any worsening symptoms or any other concerns. Right arm pain suspect secondary to pneumococcal vaccine possible adverse reaction.
Information has been received from a nursing assistant concerning a female of unknown age. No medical history or concomitant medications were reported. It was reported that on 05-DEC-2014 an expired dose of M-M-R II was administered to the patient. No adverse effects were reported. No additional information was provided. Additional information has been requested.
p/ pt recv vax approx 13 days later pt devel 5 lesions resembling chickenpox at the PPD site
17 year-old patient received Moderna's first dose; Patient didn't receive second dose; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (17 year-old patient received Moderna's first dose) and PRODUCT DOSE OMISSION ISSUE (Patient didn't receive second dose) in a 17-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Apr-2021, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (17 year-old patient received Moderna's first dose) and PRODUCT DOSE OMISSION ISSUE (Patient didn't receive second dose). On 02-Apr-2021, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (17 year-old patient received Moderna's first dose) had resolved. At the time of the report, PRODUCT DOSE OMISSION ISSUE (Patient didn't receive second dose) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       concomitant medications  were not reported Treatment was not specified  Age was recorded as received from health authority. Unable to clarify or confirm.
Patient descibed reaction as low grade fever, muscle aches and fatigue lasting around 24 - 48 hours.
Pain in Arm; Pain and swelling below right arm pit; Headache; Nausea
Headache, low grade fever. Treated with naproxen, headache was relieved, fever persisted.
Swelled, hard 2 inch diameter fever at injection site, pain at injection site, muscle ache whole arm, unable to lift arm without pain.
got covid and was vaccinated; got covid and was vaccinated; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP), Program ID: (173415). The reporter is the patient.  An adult patient received BNT162b2 (BNT162B2), as dose 1, single (Batch/Lot number: unknown) and as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. It was unknown whether the patient took other medications (Including over-the-counter medications, nutritional and herbal supplements, etc.) or not. It was unknown whether the patient had past medical history, family history and social history (Including occupational history, use of alcohol, tobacco, or recreational drugs) or not. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "got covid and was vaccinated". Clinical course: patient was not thrilled about the vaccine even though patient had both doses of Pfizer vaccine. Then my 19-year-old daughter got covid and she was vaccinated, so patient guess, patient considered that one of the rare breakthrough cases and then patient got covid. Also had very little symptoms, but it seems like now it wasn't just rare breakthrough cases, it was everybody's getting covid whether you're vaccinated or not.  No follow-up attempts are possible: Batch or lot number is not available. No further information is expected.
Arm was sore; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 59 year-old female patient received bnt162b2 (BNT162B2), intramuscular, administered in arm left, administration date 25Feb2022 (Batch/Lot number: unknown) at the age of 59 years as dose 3 (booster), single for covid-19 immunisation. Relevant medical history included: "Blood cholesterol" (unspecified if ongoing), notes: Verbatim: Cholesterol. Concomitant medication(s) included: SIMVASTATIN taken for blood cholesterol. Vaccination history included: Covid-19 vaccine (Primary Immunization series complete but unknown manufacturer), for covid 19 immunization. The following information was reported: PAIN IN EXTREMITY (non-serious) with onset 2022, outcome "unknown", described as "Arm was sore".  Additional information: It was reported that she only had the reactions for just say Saturday and her arm was sore, Yesterday very little but she was okay. No Prior vaccinations (within 4 weeks).  The lot number for bnt162b2 was not provided and will be requested during follow up.
100.2 fever for 24 hours, 7 days later reddening of skin with raised skin and pruritus'
Left arm, from elbow up has continued soreness, sensitivity, weak and tired feeling. I have range of motion, per Doctor.
Patient was given pneumococcal vaccine in L Deltoid on 3/14/09 @ 1722. Patient noted that her arm was very sore. On 3/15/09 @ 2038 RN noted that "deltoid areas of arms painful. L deltoid erythematous." Patient's L arm is red, swollen hot and itchy from L deltoid to 2-3" below L elbow. Patient received blood transfusions during the day shift on 3/15/09 through R arm. Applying BENADYL cream to arm for itch. Patient started on rifampin and BACTRIM DS for infection/cellulitis precaution b/c of Hx. of heart valve replacement.
The medication is ZOSTAVAX. I received the injection from my doctor. One month after receiving the injection my legs, arms and torso broke out severe body rash call nummular dermatitis. I went to see a dermatologist. He said that one of the reasons is that my immune system was compromised. I told him I had never had a skin allergy in my life (I am 67 years old). My condition after one year is worse. My right leg is now cover in these 30 red circles size ranging from a dime to a silver dollar. My left leg has a little less. My arms have about 20 marks. He tried some treatment. But there is no help for this. It has to go away on its own. It could take years if event can come back. It definitely is the result of this injection. I have no allergies. I don't know what else to do except to tell you. I would like to know if anyone else has had this serious a reaction. Thank you.
About 11 hours after the vaccine, I had the chills like very bad chills, my husband had to give me blankets to keep warm, I went to bed early that night but did not sleep well because I had the chills all night long, I woke up the next morning and felt groggy and ate some toast and went back to sleep, I got up again and took my meds, and went back to sleep, I got up again and had a low grade fever and still had the chills and a very bad headache and I went to lay down around 2:30PM and got back up around 05:30PM but went to bed early due to have an tickle in my throat. I took some elderberry tablets for that tickle and went to bed, the next morning which was the morning of the 19th I had a tickle in my throat, and it was itchy and sore so I call the Dr. for an appointment which I went to the next day on the 20th and it was stated that I had Bronchitis, and was prescribed, azithromycin; and albuterol sulfate inhaler; and methylprednisolone.
Extreme itching, very red bubble rash. Became so tight that my hand swelled.
Shoulder pain at site of injection traveling down to elbow; ongoing since vaccine was administered; unable to sleep on that side and have limited range of motion with shoulder.
presented to the ED due to chest pain and shortness of breath for the past 2 days in the setting of feeling fatigued for the past couple of weeks. Patient also stated that he has been having some bilateral leg cramping. In the ED, it was noted that the patient had low borderline blood pressures with tachycardia and tachypnea with low saturations. A CT with pulmonary embolus protocol revealed saddle embolus and findings of right heart strain.   He received TPA and Heparin, transferred to CCU. The patient denies history of major bleed, head trauma or prior clots. He does not have a significant family history for clotting but states that his mom has had a blood clot. Patient denies any recent surgeries, long travel, immobility or trauma.
severe chest pain and left shoulder down to hand and neck; severe chest pain and left shoulder down to hand and neck; internal swelling; Feeling discomfort; unable to perform daily activities; This is a spontaneous report from a contactable consumer (patient). A 63-year-old male patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: ER8727), via an unspecified route of administration, administered in arm right on 30Mar2021 13:00 (at the age of 63-years-old) as a single dose for covid-19 immunization. The vaccine was administered. The patient medical history included diabetic and blood pressure. The patient had no known allergies. The patient previously received the first dose of  BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EN6198), administered in arm left on 09Mar2021 11:30 PM (at the age of 63-years-old) for covid-19 immunization and had left shoulder joint pain for about 10 days. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient's concomitant medications were not reported. It was reported that after the second dose, on the second day (reported on 02Apr2021 at 06:00 AM) had to go to emergency hospital due to severe chest pain and left shoulder down to hand and neck. Developed internal swelling 10 times more than normal. Feeling discomfort and unable to perform daily activities. The events resulted in Emergency room/department or urgent care, Hospitalization for 1 day. No treatment was received for the events. The outcome of the events was not recovered. Since the vaccination, the patient has not been tested for COVID-19.